Vivos Therapeutics (VVOS) Institutional Ownership $2.83 -0.06 (-2.08%) (As of 10:26 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Vivos Therapeutics (NASDAQ:VVOS)CurrentInstitutional OwnershipPercentage26.35%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$709.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$38.53M Get VVOS Insider Trade Alerts Want to know when executives and insiders are buying or selling Vivos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VVOS Institutional Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Vivos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2024 Strategic Wealth Investment Group LLC100,000$252K0.0%-22.4%2.096% 2/13/2024 Armistice Capital LLC57,000$709K0.0%N/A4.286% 1/16/2024 Strategic Wealth Investment Group LLC128,789$1.60M0.2%-96.0%9.683% 4/24/2023 Strategic Wealth Investment Group LLC3,219,705$1.10M0.2%N/A12.874% 4/20/2023 Strategic Wealth Investment Group LLC232,737$1.10M0.2%N/A0.931% 4/18/2023Godsey & Gibb Inc.92,999$32K0.0%N/A0.372% Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/10/2023 Bard Associates Inc.201,704$81K0.0%-6.9%0.806% 11/16/2022 SeaCrest Wealth Management LLC40,000$26K0.0%N/A0.174% 11/9/2022 Boston Partners78,454$51K0.0%-36.8%0.341% 11/4/2022 Russell Investments Group Ltd.365,901$236K0.0%-11.1%1.590% 10/24/2022 Perkins Capital Management Inc.56,500$37K0.0%-65.5%0.246% 7/29/2022 Perkins Capital Management Inc.163,800$211K0.2%+9.2%0.712% 7/29/2022 Russell Investments Group Ltd.411,589$530K0.0%-3.1%1.789% 5/10/2022 Boston Partners137,354$368K0.0%+27.2%0.597% 5/5/2022 Russell Investments Group Ltd.424,801$1.14M0.0%+39.2%1.846% 5/2/2022National Asset Management Inc.98,574$265K0.0%+24.4%0.428% 4/20/2022 Perkins Capital Management Inc.150,050$402K0.3%+10.3%0.652% 4/12/2022 Griffin Asset Management Inc.70,200$188K0.0%+63.3%0.305% 2/10/2022 Perkins Capital Management Inc.136,050$306K0.2%-7.1%0.591% 2/4/2022 Boston Partners108,015$243K0.0%+131.5%0.469% 2/3/2022 Cambridge Investment Research Advisors Inc.19,200$43K0.0%+60.0%0.083% 1/28/2022 Griffin Asset Management Inc.43,000$97K0.0%-13.1%0.187% 1/28/2022National Asset Management Inc.79,270$179K0.0%+55.5%0.344% 1/21/2022 Russell Investments Group Ltd.305,096$684K0.0%+554.0%1.326% 11/16/2021 Schonfeld Strategic Advisors LLC34,443$139K0.0%N/A0.151% 11/16/2021National Asset Management Inc.50,987$206K0.0%+46.9%0.224% 11/16/2021 Two Sigma Investments LP157,324$636K0.0%N/A0.690% 11/12/2021 WMS Partners LLC12,167$49K0.0%-27.0%0.053% 11/12/2021 Blueshift Asset Management LLC18,826$76K0.0%N/A0.083% 11/9/2021BlackRock Inc.48,905$198K0.0%+255.8%0.214% 11/8/2021Avalon Investment & Advisory329,322$1.33M0.0%+73.6%1.444% 11/8/2021 Russell Investments Group Ltd.46,651$188K0.0%N/A0.205% 11/5/2021 Boston Partners46,651$188K0.0%N/A0.205% 11/2/2021 Cambridge Investment Research Advisors Inc.12,000$48K0.0%-68.0%0.053% 10/25/2021 Perkins Capital Management Inc.146,500$592K0.4%-9.8%0.642% 8/17/2021 Walleye Capital LLC150,000$743K0.0%N/A0.658% 8/16/2021 WMS Partners LLC16,667$153K0.0%N/A0.073% 8/16/2021 Archon Capital Management LLC215,000$1.06M0.1%N/A0.942% 8/13/2021 Renaissance Technologies LLC19,200$95K0.0%N/A0.084% 8/13/2021 Northern Trust Corp11,483$57K0.0%N/A0.050% “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide!8/13/2021 Geode Capital Management LLC47,661$235K0.0%+285.0%0.209% 8/13/2021 Vanguard Group Inc.383,891$1.90M0.0%N/A1.683% 8/12/2021 Bard Associates Inc.215,500$1.07M0.3%N/A0.945% 8/11/2021 Millrace Asset Group Inc.93,993$465K0.2%N/A0.412% 8/10/2021National Asset Management Inc.34,718$172K0.0%+21.9%0.152% 8/10/2021 Cambridge Investment Research Advisors Inc.37,551$186K0.0%N/A0.165% 7/30/2021Avalon Investment & Advisory189,739$939K0.0%+12.0%0.832% 5/21/2021 Citadel Advisors LLC15,846$105K0.0%N/A0.069% 5/18/2021 Millennium Management LLC78,898$524K0.0%-5.4%0.346% 5/18/2021 Citadel Advisors LLC15,846$105K0.0%N/A0.069% 5/14/2021Alpha Paradigm Partners LLC9,921$66K0.0%N/A0.054% 5/14/2021 K.J. Harrison & Partners Inc45,419$302K0.0%-50.3%0.249% 5/13/2021Avalon Investment & Advisory169,414$1.13M0.0%N/A0.930% 5/12/2021 Geode Capital Management LLC12,380$82K0.0%N/A0.068% 5/10/2021 Royce & Associates LP348,000$2.31M0.0%+16.0%1.911% 5/7/2021BlackRock Inc.11,541$77K0.0%N/A0.063% 5/4/2021 Griffin Asset Management Inc.59,700$396K0.1%N/A0.328% 2/17/2021 Jane Street Group LLC32,237$191K0.0%N/A0.182% 2/16/2021 Walleye Capital LLC74,500$440K0.0%N/A0.422% 2/9/2021 Perkins Capital Management Inc.20,000$118K0.1%N/A0.113% 2/8/2021 Royce & Associates LP300,000$1.77M0.0%N/A1.698% 2/8/2021 K.J. Harrison & Partners Inc91,322$540K0.1%N/A0.517% (Data available from 1/1/2016 forward) VVOS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VVOS shares? During the previous two years, the following institutional investors and hedge funds held shares of Vivos Therapeutics shares: Armistice Capital LLC ($709K), Strategic Wealth Investment Group LLC ($252K), and Bard Associates Inc. ($81K), Godsey & Gibb Inc. ($32K).Learn more on VVOS's institutional investors. What percentage of Vivos Therapeutics stock is owned by institutional investors? 26.35% of Vivos Therapeutics stock is owned by institutional investors. Learn more on VVOS's institutional investor holdings. Which institutional investors have been buying Vivos Therapeutics stock? The following institutional investors have purchased Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.45M), Godsey & Gibb Inc. ($93.00K), and Armistice Capital LLC ($57K). How much institutional buying is happening at Vivos Therapeutics? Institutional investors have bought a total of 3,602,441 shares in the last 24 months. This purchase volume represents approximately $30.94M in transactions. Which Vivos Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Vivos Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($3.12M), and Bard Associates Inc. ($15K). How much institutional selling is happening at Vivos Therapeutics? Institutional investors have sold a total of 3,134,705 shares in the last 24 months. This volume of shares sold represents approximately $38.68M in transactions. Related Companies Nutriband Institutional Ownership Cytosorbents Institutional Ownership Apyx Medical Institutional Ownership CollPlant Biotechnologies Institutional Ownership Nexalin Technology Institutional Ownership Bellevue Life Sciences Acquisition Institutional Ownership Envoy Medical Institutional Ownership iCAD Institutional Ownership SurgePays Institutional Ownership Outset Medical Institutional Ownership This page (NASDAQ:VVOS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
